ERCOLINO, TONINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.070
EU - Europa 1.534
AS - Asia 408
AF - Africa 10
Totale 4.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.066
RU - Federazione Russa 569
PL - Polonia 368
SE - Svezia 174
IE - Irlanda 145
IT - Italia 143
SG - Singapore 135
HK - Hong Kong 86
CN - Cina 74
JO - Giordania 47
FI - Finlandia 28
IN - India 27
CH - Svizzera 26
DE - Germania 24
GB - Regno Unito 24
KR - Corea 19
BE - Belgio 13
UA - Ucraina 10
VN - Vietnam 10
CI - Costa d'Avorio 9
TR - Turchia 9
CA - Canada 4
ES - Italia 3
FR - Francia 3
NL - Olanda 2
BY - Bielorussia 1
IR - Iran 1
RO - Romania 1
SC - Seychelles 1
Totale 4.022
Salva come PNG Salva come JPEG
Città #
Warsaw 368
Santa Clara 324
Fairfield 272
Chandler 159
Dublin 145
Ashburn 135
Woodbridge 132
Singapore 115
Seattle 114
Cambridge 100
Ann Arbor 87
Houston 84
Wilmington 83
Hong Kong 54
Altamura 50
Lawrence 50
Princeton 37
Florence 34
Beijing 33
Moscow 33
Boston 26
Buffalo 26
Jacksonville 26
Bern 24
Boardman 21
San Diego 19
Seoul 19
Shanghai 18
Mumbai 15
New York 14
Brussels 13
Kent 13
Medford 11
Abidjan 9
Izmir 9
Dong Ket 8
Los Angeles 7
Yubileyny 6
Chennai 5
Helsinki 5
Hillsboro 5
Andover 4
Bologna 4
Bremen 4
Milan 4
Norwalk 4
Old Bridge 4
Phoenix 4
Pune 4
West Jordan 4
Chiswick 3
Lappeenranta 3
Prato 3
Redmond 3
Toronto 3
Barcelona 2
Brooklyn 2
Cagliari 2
Düsseldorf 2
Falls Church 2
Guangzhou 2
Melito Di Napoli 2
Nanjing 2
Paris 2
Pisa 2
Redwood City 2
Rome 2
Volketswil / Volketswil (Dorf) 2
Xi'an 2
Xuzhou 2
Arezzo 1
Auburn Hills 1
Bangalore 1
Bethlehem 1
Carson 1
Costa Mesa 1
Ferentino 1
Fontebuona 1
Frankfurt am Main 1
Fucecchio 1
Gonnoscodina 1
Hefei 1
Indianapolis 1
Langhirano 1
Laurel 1
London 1
Madrid 1
Nürnberg 1
Ottawa 1
Portland 1
Prescot 1
Prineville 1
Rottofreno 1
Salerno 1
Scarperia 1
Sezze 1
Shaoxing 1
Tappahannock 1
Turin 1
Venice 1
Totale 2.819
Salva come PNG Salva come JPEG
Nome #
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 271
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 227
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 226
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 143
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 143
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 132
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 128
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 121
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 118
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 118
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 114
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 110
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 109
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. 107
Caratterizzazione genomica del carcinoma surrenalico 106
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 105
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 104
Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma 98
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 97
Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes. 94
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas 90
Malignant extra-adrenal pheochromocytoma caused by an SDHB intronic variation leading to a 54-bp deletion in exon 4. 88
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 87
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 87
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 82
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 79
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 78
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 75
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics 72
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 71
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 69
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von hippel lindau syndrome 64
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer 63
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience 60
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 59
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 59
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 57
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. 50
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma 50
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 44
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 22
Totale 4.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020433 0 0 0 0 62 67 73 68 57 47 51 8
2020/2021416 33 32 43 27 34 52 21 30 42 45 28 29
2021/2022277 11 25 24 13 10 12 14 31 7 18 45 67
2022/2023766 59 174 32 46 53 111 92 31 114 9 15 30
2023/2024333 11 32 41 16 20 46 11 67 13 26 42 8
2024/20251.169 59 207 130 370 403 0 0 0 0 0 0 0
Totale 4.077